Mostyn Law has represented many clients affected by Risperdal, a medication manufactured by Johnson & Johnson (J&J) and approved by the FDA as an antipsychotic medication. Despite the FDA approved purpose, J&J marketed Risperdal for use in children with mental disabilities, including autism, attention deficit disorder, hyperactivity, and oppositional defiant disorder. Many adolescent boys taking Risperdal experienced weight gain and breast development, some even requiring breast reduction surgery.
We are committed to helping individuals harmed by the effects of Risperdal and we will fight to make sure that you get the compensation that you deserve.
Our team has experienced fighters to litigate your case.
Prior results do not guarantee a similar outcome.